214 related articles for article (PubMed ID: 2471468)
1. Abnormal organization of keratin intermediate filaments in cultured keratinocytes of epidermolysis bullosa simplex.
Kitajima Y; Inoue S; Yaoita H
Arch Dermatol Res; 1989; 281(1):5-10. PubMed ID: 2471468
[TBL] [Abstract][Full Text] [Related]
2. [Cytoskeletal disorders in human keratinocytes--epidermolysis bullosa simplex].
Kitajima Y; Jokura Y; Yaoita H
Hum Cell; 1991 Jun; 4(2):123-30. PubMed ID: 1720328
[TBL] [Abstract][Full Text] [Related]
3. Temperature sensitivity of the keratin cytoskeleton and delayed spreading of keratinocyte lines derived from EBS patients.
Morley SM; Dundas SR; James JL; Gupta T; Brown RA; Sexton CJ; Navsaria HA; Leigh IM; Lane EB
J Cell Sci; 1995 Nov; 108 ( Pt 11)():3463-71. PubMed ID: 8586658
[TBL] [Abstract][Full Text] [Related]
4. Alteration in the arrangement of the keratin-type intermediate filaments during mitosis in cultured human keratinocytes.
Kitajima Y; Inoue S; Yoneda K; Mori S; Yaoita H
Eur J Cell Biol; 1985 Sep; 38(2):219-25. PubMed ID: 2412816
[TBL] [Abstract][Full Text] [Related]
5. Epidermolysis bullosa simplex (Dowling-Meara type) is a genetic disease characterized by an abnormal keratin-filament network involving keratins K5 and K14.
Ishida-Yamamoto A; McGrath JA; Chapman SJ; Leigh IM; Lane EB; Eady RA
J Invest Dermatol; 1991 Dec; 97(6):959-68. PubMed ID: 1721080
[TBL] [Abstract][Full Text] [Related]
6. Reorganization of keratin intermediate filaments by the drug-induced disruption of microfilaments in cultured human keratinocytes.
Kitajima Y; Inoue S; Yaoita H
J Invest Dermatol; 1986 Nov; 87(5):565-9. PubMed ID: 2430025
[TBL] [Abstract][Full Text] [Related]
7. Supplementation of a mutant keratin by stable expression of desmin in cultured human EBS keratinocytes.
Magin TM; Kaiser HW; Leitgeb S; Grund C; Leigh IM; Morley SM; Lane EB
J Cell Sci; 2000 Dec; 113 Pt 23():4231-9. PubMed ID: 11069768
[TBL] [Abstract][Full Text] [Related]
8. Keratin expression in epidermolysis bullosa simplex (Dowling-Meara).
Tidman MJ; Eady RA; Leigh IM; MacDonald DM
Acta Derm Venereol; 1988; 68(1):15-20. PubMed ID: 2449006
[TBL] [Abstract][Full Text] [Related]
9. Ultrastructural findings in epidermolysis bullosa.
Smith LT
Arch Dermatol; 1993 Dec; 129(12):1578-84. PubMed ID: 7504435
[TBL] [Abstract][Full Text] [Related]
10. Different effects of pemphigus antibody and plasmin on the distribution of keratin intermediate filaments and desmoplakins between cultured oral and epidermal keratinocytes.
Jinbu Y; Kitajima Y; Koto S; Akasaka Y; Yaoita H
J Dermatol Sci; 1992 Jan; 3(1):6-12. PubMed ID: 1375506
[TBL] [Abstract][Full Text] [Related]
11. Keratins as an Inflammation Trigger Point in Epidermolysis Bullosa Simplex.
Evtushenko NA; Beilin AK; Kosykh AV; Vorotelyak EA; Gurskaya NG
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830328
[TBL] [Abstract][Full Text] [Related]
12. Distinct Impact of Two Keratin Mutations Causing Epidermolysis Bullosa Simplex on Keratinocyte Adhesion and Stiffness.
Homberg M; Ramms L; Schwarz N; Dreissen G; Leube RE; Merkel R; Hoffmann B; Magin TM
J Invest Dermatol; 2015 Oct; 135(10):2437-2445. PubMed ID: 25961909
[TBL] [Abstract][Full Text] [Related]
13. Hemidesmosomes show abnormal association with the keratin filament network in junctional forms of epidermolysis bullosa.
McMillan JR; McGrath JA; Tidman MJ; Eady RA
J Invest Dermatol; 1998 Feb; 110(2):132-7. PubMed ID: 9457907
[TBL] [Abstract][Full Text] [Related]
14. The relationship between intermediate filaments and microfilaments before and during the formation of desmosomes and adherens-type junctions in mouse epidermal keratinocytes.
Green KJ; Geiger B; Jones JC; Talian JC; Goldman RD
J Cell Biol; 1987 May; 104(5):1389-402. PubMed ID: 2437129
[TBL] [Abstract][Full Text] [Related]
15. Keratin mutations of epidermolysis bullosa simplex alter the kinetics of stress response to osmotic shock.
D'Alessandro M; Russell D; Morley SM; Davies AM; Lane EB
J Cell Sci; 2002 Nov; 115(Pt 22):4341-51. PubMed ID: 12376565
[TBL] [Abstract][Full Text] [Related]
16. Dyskeratosis as a histologic feature in epidermolysis bullosa simplex-Dowling Meara.
Bergman R; Harel A; Sprecher E
J Am Acad Dermatol; 2007 Sep; 57(3):463-6. PubMed ID: 17707151
[TBL] [Abstract][Full Text] [Related]
17. A cell-based drug discovery assay identifies inhibition of cell stress responses as a new approach to treatment of epidermolysis bullosa simplex.
Tan TS; Common JEA; Lim JSY; Badowski C; Firdaus MJ; Leonardi SS; Lane EB
J Cell Sci; 2021 Oct; 134(19):. PubMed ID: 34643242
[TBL] [Abstract][Full Text] [Related]
18. Treatment of keratinocytes with 4-phenylbutyrate in epidermolysis bullosa: Lessons for therapies in keratin disorders.
Spörrer M; Prochnicki A; Tölle RC; Nyström A; Esser PR; Homberg M; Athanasiou I; Zingkou E; Schilling A; Gerum R; Thievessen I; Winter L; Bruckner-Tuderman L; Fabry B; Magin TM; Dengjel J; Schröder R; Kiritsi D
EBioMedicine; 2019 Jun; 44():502-515. PubMed ID: 31078522
[TBL] [Abstract][Full Text] [Related]
19. A human keratin 14 "knockout": the absence of K14 leads to severe epidermolysis bullosa simplex and a function for an intermediate filament protein.
Chan Y; Anton-Lamprecht I; Yu QC; Jäckel A; Zabel B; Ernst JP; Fuchs E
Genes Dev; 1994 Nov; 8(21):2574-87. PubMed ID: 7525408
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities of basal cell keratin in epidermolysis bullosa simplex do not affect the expression patterns of suprabasal keratins and cornified cell envelope proteins.
Sasaki Y; Shimizu H; Akiyama M; Yoneda K; Ishida-Yamamoto A; Watanabe S; Hata J; Nishikawa T
Arch Dermatol Res; 1998 Nov; 290(11):591-7. PubMed ID: 9860278
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
